Advertisement

Bladder Cancer

  • Michael A. Garcia
  • Albert J. Chang
Chapter

Abstract

This chapter will discuss workup, diagnosis, and management of bladder cancer with an emphasis on radiation therapy and published data.

Keywords

Bladder cancer Urothelial cell carcinoma Bladder preservation Radiation therapy Cystectomy 

Notes

Acknowledgment

We thank William Foster MD, Brian Lee MD, PhD, and Joycelyn L. Speight MD, PhD, for their work on the prior edition of this chapter.

References

  1. American Cancer Society. Bladder cancer. Atlanta: American Cancer Society; 2016.Google Scholar
  2. Amin, MB, Edge, S, Greene, F, Byrd, DR, Brookland, RK, Washington, MK, Gershenwald, JE, Compton, CC, Hess, KR, Sullivan, DC, Jessup, JM, Brierley, JD, Gaspar, LE, Schilsky, RL, Balch, CM, Winchester, DP, Asare, EA, Madera, M, Gress, DM, Meyer, LR (editos). AJCC cancer staging manual, 8th edition. Springer; 2017Google Scholar
  3. Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys. 2016;96(1):78–86.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Christodouleas JP, Hwang W-T, Baumann BC. Adjuvant radiation for locally advanced bladder cancer? A question worth asking. Int J Radiat Oncol Biol Phys. 2016;94(5):1040–2.CrossRefPubMedGoogle Scholar
  5. Coppin CM, Gospodarowicz MK, James K, et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1996;14:2901–7.CrossRefPubMedGoogle Scholar
  6. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (editors). AJCC cancer staging manual, 7th edition. Springer; 2010.Google Scholar
  7. Efstathiou JA, Bae K, Shipley WU, et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol. 2009;27(25):4055–61.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Efstathiou JA, Spiegel DY, Shipley WU, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012;61(4):705–11.CrossRefPubMedGoogle Scholar
  9. Granfors T, Tomic R, Ljungberg B. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma. Scand J Urol Nephrol. 2009;43(4):293–9.CrossRefPubMedGoogle Scholar
  10. Harland SJ, Kynaston H, Grigor K, et al. A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. J Urol. 2007;178:807–13.CrossRefPubMedGoogle Scholar
  11. Huddart RA, Hall E, Hussain SA, et al. Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004). Int J Radiat Oncol Biol Phys. 2013;87(2):261–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012;366(16):1477–88.CrossRefPubMedGoogle Scholar
  13. Mak RH, Hunt D, Shipley WU, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2014;32(34):3801–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: bladder cancer v.2.2016. Available at: http://www.nccn.org/professionals/physician_gls/PDF/bladder.pdf
  15. Stein JP, Lieskovsky G, Skinner DG, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75.CrossRefPubMedGoogle Scholar
  16. Weiss C, Wolze C, Rodel C, et al. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy? J Clin Oncol. 2006;24(15):2318–24.CrossRefPubMedGoogle Scholar
  17. Yuan H, Qiu J, Liu L, et al. Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trials. Real FX, ed. PLoS One. 2013;8(9):e74142.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Zietman AL, Sacco D, Skowronski U, et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol. 2003;170:1772–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation Oncology, University of California San FranciscoSan FranciscoUSA

Personalised recommendations